Blood filtration improves safety of blood transfusions

White blood cells can cause costly complications following transfusions; the US and Germany are joining the list of countries requiring filtration of donor blood to remove them.

Written byJohn Borchardt
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

HOUSTON. Every three seconds someone in the world needs a blood transfusion. White blood cells (leukocytes) in donor blood can cause serious medical complications, as many viruses (including cytomegalovirus, Human T-cell Lymphotrophic virus and Epstein-Barr virus) and bacteria (including Yersinia) are harboured in leukocytes. Blood donors are typically screened for only a few of these contaminants.

Leukocytes in transfused blood can also suppress the recipient's immune system. Immunosuppression may lead to multiple organ failure, increased risk of post-surgical infection and diminished prospect of cure for patients with certain malignancies. Refractoriness (resistance) occurs when a patient reacts to leukocytes in donated blood and creates antibodies. This immune response, known as 'alloimmunization', can cause resistance to subsequent platelet transfusions; patients do not respond to the transfusion and so have an increased risk of spontaneous bleeding. Febrile non-hemolytic transfusion reaction is characterised by a 1°C or more rise in body temperature within 24 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies